301
|
Banovic MD, Nikolic SD. Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis. Curr Probl Cardiol 2017; 43:335-354. [PMID: 29290389 DOI: 10.1016/j.cpcardiol.2017.12.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient' life. In the past 15 years, the novel treatment strategy in subgroups of symptomatic patients with AS have been the subject of extensive research, starting from introduction of transcatheter aortic valve implant (TAVI) in inoperable symptomatic patients with severe AS and continuing further to patients with very high and high operative risk. In the past few years, the focus has further shifted toward the patients with lower operative risk, as well as to asymptomatic patients with severe AS. In the former group, the question relates to whether TAVI is beneficial when compared to SAVR in intermediate- to low-risk patients with symptomatic AS. In the latter group, the main issue is if and when the SAVR should be performed. This article analyzes current status and evidences regarding treatment strategies in symptomatic high, intermediate, low-risk, and asymptomatic patients with isolated severe AS.
Collapse
|
302
|
Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B, Mangieri A, Deutsch MA, Ubben T, Deuschl F, Kuwata S, De Biase C, Williams T, Dhoble A, Kim WK, Ferrari E, Barbanti M, Vollema EM, Miceli A, Giannini C, Attizzani GF, Kong WK, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T, Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C, Ensminger SM, Hildick-Smith D, Petronio AS, Yin WH, De Marco F, Testa L, Van Mieghem NM, Whisenant BK, Kuck KH, Colombo A, Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol 2017; 70:2752-2763. [DOI: 10.1016/j.jacc.2017.10.006] [Citation(s) in RCA: 108] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Revised: 09/19/2017] [Accepted: 10/02/2017] [Indexed: 10/18/2022]
|
303
|
Mahtta D, Elgendy IY, Bavry AA. From CoreValve to Evolut PRO: Reviewing the Journey of Self-Expanding Transcatheter Aortic Valves. Cardiol Ther 2017; 6:183-192. [PMID: 29080095 PMCID: PMC5688966 DOI: 10.1007/s40119-017-0100-z] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Indexed: 12/31/2022] Open
Abstract
Transcatheter aortic valve replacement (TAVR) has become standard therapy for patients with severe aortic stenosis who are deemed at least intermediate risk for surgical valve replacement. Over the past decade, several technological advances have taken place to improve the quality and safety of these devices. The current commercially available valves are broadly grouped into balloon expandable and self-expandable valves. The latest iteration of the self-expandable valve is Medtronic's repositionable valve known as the Evolut PRO system. In this review, we highlight the evidence behind the use of TAVR, improvement in devices over previous generations, clinical evidence behind the CoreValve Evolut PRO system, and the future of TAVR.
Collapse
Affiliation(s)
- Dhruv Mahtta
- Department of Medicine, University of Florida, Gainesville, FL, USA
| | - Islam Y Elgendy
- Division of Cardiology, Department of Medicine, University of Florida, Gainesville, FL, USA
| | - Anthony A Bavry
- Division of Cardiology, Department of Medicine, University of Florida, Gainesville, FL, USA.
- North Florida/South Georgia Veterans Health System, Gainesville, FL, USA.
| |
Collapse
|
304
|
Shibata N, Matsumoto K, Toba T, Mori S, Shimoyama S, Tanaka H, Shinke T, Hirata KI. The first case of “locked-in leaflet” after transcatheter aortic valve replacement in a patient with bicuspid aortic stenosis. Echocardiography 2017; 35:110-113. [DOI: 10.1111/echo.13756] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- Nao Shibata
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Kensuke Matsumoto
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Takayoshi Toba
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Shumpei Mori
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Shinsuke Shimoyama
- Department of Radiology; Kobe University Graduate School of Medicine; Kobe Japan
| | - Hidekazu Tanaka
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Toshiro Shinke
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Ken-ichi Hirata
- Division of Cardiovascular Medicine; Department of Internal Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| |
Collapse
|
305
|
Pasala TKR, Ruiz CE. Transcatheter Aortic Valve Replacement for All-comers With Severe Aortic Stenosis: Could It Become a Reality? ACTA ACUST UNITED AC 2017; 71:141-145. [PMID: 29107502 DOI: 10.1016/j.rec.2017.09.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Accepted: 09/12/2017] [Indexed: 11/17/2022]
Affiliation(s)
- Tilak K R Pasala
- Structural and Congenital Heart Center, Hackensack University Medical Center, Hackensack, New Jersey, United States
| | - Carlos E Ruiz
- Structural and Congenital Heart Center, Hackensack University Medical Center, Hackensack, New Jersey, United States.
| |
Collapse
|
306
|
Sannino A, Cedars A, Stoler RC, Szerlip M, Mack MJ, Grayburn PA. Comparison of Efficacy and Safety of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Versus Tricuspid Aortic Valves. Am J Cardiol 2017; 120:1601-1606. [PMID: 28886853 DOI: 10.1016/j.amjcard.2017.07.053] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Revised: 07/03/2017] [Accepted: 07/10/2017] [Indexed: 01/10/2023]
Abstract
Bicuspid aortic valve (BAV) stenosis has been considered a contraindication to transcatheter aortic valve implantation (TAVI). The aim of this study is to compare the efficacy and safety of TAVI in patients with BAV with those with tricuspid aortic valve (TAV) using balloon-expandable and self-expanding transcatheter heart valves. This retrospective study included 823 consecutive patients with severe, symptomatic aortic valve stenosis undergoing TAVI in 2 institutions, Baylor Heart and Vascular Hospital (Dallas, TX) and The Heart Hospital Baylor Plano (Plano, TX), from January 2012 to February 2016. Efficacy was evaluated by postprocedural valve function as mean gradient, peak velocity, effective orifice area, and ≥moderate paravalvular leak. Safety end points included all-cause 30-day and 1-year mortality, immediate postprocedural mortality and 30-day cardiovascular mortality, procedural success, pacemaker implantation, and procedural complications. Of the 823 included patients, 735 had TAV and 77 had BAV. Baseline characteristics were similar between the 2 groups. Procedural success was high in both BAV and TAV (98.7% vs 99.1%, p = ns). There were no significant differences between groups in valve hemodynamics after TAVI, pacemaker implantation rate, or procedural complications. There were no differences regarding immediate postprocedural mortality (BAV vs TAV, 1.1% vs 0.8%, p = ns), nor 30-day cardiovascular mortality (3.4% vs 2.3%, p = ns). All-cause mortality at 30 days (3.4% vs 3.1%, p = ns) and 1-year (8.5% vs 10.5%) were similar. Patients with BAV showed similar procedural and clinical outcomes to patients with TAV. Therefore, TAVI appears to be a safe and effective procedure for patients with BAVs as well as those with TAVs.
Collapse
|
307
|
Barbanti M, Tamburino C, Capodanno D. Hot topics in transcatheter aortic valve implantation. Future Cardiol 2017; 13:503-506. [DOI: 10.2217/fca-2017-0058] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
- Marco Barbanti
- Division of Cardiology – Cardio-Thoracic-Vascular Department, AOU ‘Policlinico-Vittorio Emanuele’, University of Catania, Catania, Italy
| | - Corrado Tamburino
- Division of Cardiology – Cardio-Thoracic-Vascular Department, AOU ‘Policlinico-Vittorio Emanuele’, University of Catania, Catania, Italy
- ETNA Foundation, Catania, Italy
| | - Davide Capodanno
- Division of Cardiology – Cardio-Thoracic-Vascular Department, AOU ‘Policlinico-Vittorio Emanuele’, University of Catania, Catania, Italy
| |
Collapse
|
308
|
Mariathas M, Rawlins J, Curzen N. Transcatheter aortic valve implantation: where are we now? Future Cardiol 2017; 13:551-566. [DOI: 10.2217/fca-2017-0056] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Transcatheter aortic valve implantation (TAVI) was first used in clinical practice in 2002. Since 2002, there has been a rapid increase in TAVI activity in patients with symptomatic severe aortic stenosis. This has been supported by systematic randomized data comparing TAVI against the gold standard treatment for the last 50 years’ surgical aortic valve replacement. TAVI is now currently a recommended therapeutic intervention in the treatment of severe aortic stenosis patients who are deemed either high risk or inoperable. The indications for TAVI continue to expand. Within this review we will focus on the current guidelines for TAVI, the evidence for it, the complications of TAVI, postprocedure care, the technology available to clinicians now and finally the future perspectives for TAVI.
Collapse
Affiliation(s)
- Mark Mariathas
- Coronary Research Group, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
- Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK
| | - John Rawlins
- Coronary Research Group, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
| | - Nick Curzen
- Coronary Research Group, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
- Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK
| |
Collapse
|
309
|
Patel SV, Sonani R, Singh V, Patel P, Badheka A. Outcomes of transcatheter aortic valve replacement for bicuspid aortic stenosis – a systematic review of existing literature. Expert Rev Pharmacoecon Outcomes Res 2017; 17:579-585. [DOI: 10.1080/14737167.2017.1391692] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Samir V. Patel
- Department of Medicine, Sparks Health Systems, Fort Smith, AR, USA
| | - Rajesh Sonani
- Department of Medicine, Brandon Regional Hospital, Brandon, FL, USA
| | - Vikas Singh
- Massachusetts General Hospital, Harvard School of Medicine, MA, USA
| | - Palak Patel
- Department of Health Sciences, Massachusetts College of Pharmacy and Health sciences, MA, USA
| | | |
Collapse
|
310
|
Kong WKF, Regeer MV, Poh KK, Yip JW, van Rosendael PJ, Yeo TC, Tay E, Kamperidis V, van der Velde ET, Mertens B, Ajmone Marsan N, Delgado V, Bax JJ. Inter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve. Eur Heart J 2017; 39:1308-1313. [DOI: 10.1093/eurheartj/ehx562] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2017] [Accepted: 09/17/2017] [Indexed: 12/22/2022] Open
Affiliation(s)
- William K F Kong
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
- Department of Cardiology, National University Heart Centre, National University Health System, 5 Lower Kent Ridge Rd, 119074 Singapore
| | - Madelien V Regeer
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
| | - Kian K Poh
- Department of Cardiology, National University Heart Centre, National University Health System, 5 Lower Kent Ridge Rd, 119074 Singapore
| | - James W Yip
- Department of Cardiology, National University Heart Centre, National University Health System, 5 Lower Kent Ridge Rd, 119074 Singapore
| | - Philippe J van Rosendael
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
| | - Tiong C Yeo
- Department of Cardiology, National University Heart Centre, National University Health System, 5 Lower Kent Ridge Rd, 119074 Singapore
| | - Edgar Tay
- Department of Cardiology, National University Heart Centre, National University Health System, 5 Lower Kent Ridge Rd, 119074 Singapore
| | - Vasileios Kamperidis
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
- Department of Cardiology, AHEPA University Hospital, St.Kiriakidis 1, PO Box 54636 Thessaloniki, Greece
| | - Enno T van der Velde
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
| | - Bart Mertens
- Medical Statistics Department, Leiden University Medical Center, Albinusdreef 2, 2300RC Leiden, The Netherlands
| | - Nina Ajmone Marsan
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
| | - Victoria Delgado
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
| | - Jeroen J Bax
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands
| |
Collapse
|
311
|
|
312
|
Yoon SH, Sharma R, Chakravarty T, Kawamori H, Maeno Y, Miyasaka M, Nomura T, Ochiai T, Israr S, Rami T, Nakamura M, Chen W, Makkar RR. Clinical outcomes and prognostic factors of transcatheter aortic valve implantation in bicuspid aortic valve patients. Ann Cardiothorac Surg 2017; 6:463-472. [PMID: 29062741 DOI: 10.21037/acs.2017.09.03] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
BACKGROUND The purpose of this study was to evaluate the outcomes of transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve stenosis (AS). METHODS From April 2012 and December 2016, 108 patients with bicuspid AS underwent TAVR using the Sapien XT (34 patients) and Sapien 3 (74 patients) valves. Procedural and clinical outcomes were assessed according to VARC-2 criteria and compared between the two devices. RESULTS In the overall cohort, the majority of patients were male (71.3%) with an intermediate surgical risk and a mean Society of Thoracic Surgeons (STS) score of 5.2%. Compared to the Sapien XT group, the Sapien 3 group had a significantly lower STS score (3.3%±2.0% vs. 6.7%±3.6%; P=0.001). Compared to the Sapien XT group, the Sapien 3 group had a significantly lower rate of moderate or severe paravalvular leak (2.7% vs. 14.7%; P=0.03) and higher device success (97.3% vs. 82.4%; P=0.006). There were no significant differences between the two groups in terms of 30-day all-cause mortality, stroke, life-threatening bleeding, major vascular complication and acute kidney injury (stage 2 or 3). Cumulative all-cause mortality at 1-year follow-up was 6.9%. There were no significant differences in cumulative event rates for all-cause mortality at 1-year follow-up between the two groups (9.4% vs. 4.6%; log-rank P=0.47). By univariate analysis, major vascular complication was significantly associated with overall all-cause mortality [hazard ratios (HR): 7.57; 95% confidence interval (CI): 1.51-37.86; P=0.014]. CONCLUSIONS TAVR using the balloon-expandable valves provided acceptable procedural and clinical outcomes in patients with bicuspid AS. The new-generation Sapien 3 valves showed improved procedural outcomes compared to the early-generation Sapien XT valves.
Collapse
Affiliation(s)
- Sung-Han Yoon
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Rahul Sharma
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Tarun Chakravarty
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Hiroyuki Kawamori
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Yoshio Maeno
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Masaki Miyasaka
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Takahiro Nomura
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Tomoki Ochiai
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Sharjeel Israr
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Tanya Rami
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Mamoo Nakamura
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Wen Chen
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| | - Raj R Makkar
- Department of Interventional Cardiology and Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
| |
Collapse
|
313
|
Kong WK, Delgado V, Bax JJ. Bicuspid Aortic Valve. Circ Cardiovasc Imaging 2017; 10:CIRCIMAGING.117.005987. [DOI: 10.1161/circimaging.117.005987] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Accepted: 07/26/2017] [Indexed: 01/06/2023]
Affiliation(s)
- William K.F. Kong
- From the Department of Cardiology, Leiden University Medical Center, The Netherlands (W.K.F.K., V.D., J.J.B.); and Department of Cardiology, National University Heart Center, National University Health System, Singapore (W.K.F.K.)
| | - Victoria Delgado
- From the Department of Cardiology, Leiden University Medical Center, The Netherlands (W.K.F.K., V.D., J.J.B.); and Department of Cardiology, National University Heart Center, National University Health System, Singapore (W.K.F.K.)
| | - Jeroen J. Bax
- From the Department of Cardiology, Leiden University Medical Center, The Netherlands (W.K.F.K., V.D., J.J.B.); and Department of Cardiology, National University Heart Center, National University Health System, Singapore (W.K.F.K.)
| |
Collapse
|
314
|
Outcomes of TAVR in Bicuspid Aortic Valve Stenosis. J Am Coll Cardiol 2017; 70:1684-1685. [DOI: 10.1016/j.jacc.2017.06.071] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Accepted: 06/20/2017] [Indexed: 11/21/2022]
|
315
|
Barbanti M, Webb J, Gilard M, Capodanno D, Tamburino C. Transcatheter aortic valve implantation in 2017: state of the art. EUROINTERVENTION 2017; 13:AA11-AA21. [DOI: 10.4244/eij-d-17-00567] [Citation(s) in RCA: 61] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
316
|
|
317
|
Tarantini G, Nai Fovino L, Gersh BJ. Transcatheter aortic valve implantation in lower-risk patients: what is the perspective? Eur Heart J 2017; 39:658-666. [DOI: 10.1093/eurheartj/ehx489] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Accepted: 08/02/2017] [Indexed: 12/15/2022] Open
Affiliation(s)
- Giuseppe Tarantini
- Department of Cardiac, Thoracic and Vascular Science, Padova University Hospital, Via Giustiniani 2, 35128 Padova, Italy
| | - Luca Nai Fovino
- Department of Cardiac, Thoracic and Vascular Science, Padova University Hospital, Via Giustiniani 2, 35128 Padova, Italy
| | | |
Collapse
|
318
|
Ng ACT, Wang WYS, Delgado V, Bax JJ. Bicuspid Aortic Valve Disease: New Insights. STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM 2017. [DOI: 10.1080/24748706.2017.1329572] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Affiliation(s)
- Arnold C. T. Ng
- Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands
- Centre for Advanced Imaging, The University of Queensland, Australia
- Department of Cardiology, Princess Alexandra Hospital, Faculty of Medicine, The University of Queensland, Australia
| | - William Y. S. Wang
- Centre for Advanced Imaging, The University of Queensland, Australia
- Department of Cardiology, Princess Alexandra Hospital, Faculty of Medicine, The University of Queensland, Australia
| | - Victoria Delgado
- Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands
| | - Jeroen J. Bax
- Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands
| |
Collapse
|
319
|
Abstract
The 66thAnnual Scientific Sessions and Expo of the American College of Cardiology (ACC) were held at the Walter E. Washington Convention Center, Washington DC, from March 17thto 19th, 2017. This meeting offered 23 Late-Breaking Clinical Trial (LBCT) presentations, 17 Featured Clinical Research presentations with and without LBCT, and 2,572 abstracts presented in oral and poster sessions by over 2,000 experts. This report presents the highlights of this meeting, including the opening showcase, several important LBCTs and some international joint symposiums.
Collapse
Affiliation(s)
- Takafumi Hiro
- Division of Cardiology, Department of Medicine, Nihon University School of Medicine
| |
Collapse
|
320
|
|